Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GRAIL, Inc. - Common Stock (NQ:GRAL)

81.20 -1.34 (-1.62%)
Streaming Delayed Price Updated: 9:45 AM EDT, Aug 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GRAIL, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
Important Notice to Long-Term Shareholders of Calix, Inc. (NYSE: CALX); GeneDx Holdings Corp. (NASDAQ: WGS); GRAIL, Inc. (NASDAQ: GRAL); and Verra Mobility Corporation (NASDAQ: VRRM): Grabar Law Office is Investigating Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
Law Offices of Frank R. Cruz Encourages Grail, Inc. (GRAL) Shareholders to Inquire About Securities Fraud Class Action
From Law Offices of Frank R. Cruz
Via Business Wire
News headline image
GRAL Breaking News: GRAIL, Inc. Sued for Securities Fraud after Trial Results Lead to 50% Stock Drop – Investors Notified to Contact BFA Law
From Bleichmar Fonti & Auld LLP
Via Business Wire
News headline image
Law Offices of Howard G. Smith Encourages Grail, Inc. (GRAL) Shareholders To Inquire About Securities Fraud Class Action
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
GRAL INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Grail (GRAL) Investors of Securities Class Action Lawsuit Deadline on August 4, 2026
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
Securities Fraud Investigation Into Grail, Inc. (GRAL) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
Grail, Inc. (GRAL) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages GRAIL, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GRAL
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Securities Fraud Investigation Into Grail, Inc. (GRAL) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
GRAIL LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against GRAIL, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
GRAL INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
News headline image
GRAIL, INC. (GRAL) INVESTOR ALERT Investors With Large Losses in GRAIL, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Berger Montague PC Investigating Claims on Behalf of GRAIL, Inc. (NASDAQ: GRAL) Investors After Class Action Filing
From Berger Montague
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GRAIL, Inc. of Class Action Lawsuit and Upcoming Deadlines – GRAL
From Pomerantz LLP
Via GlobeNewswire
News headline image
GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
Important Notice to Long-Term Shareholders of Badger Meter, Inc. (NYSE: BMI); GeneDx Holdings Corp. (NASDAQ: WGS); GRAIL, Inc. (NASDAQ: GRAL); and Verra Mobility Corporation (NASDAQ: VRRM): Grabar Law Office is Investigating Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
Rosen Law Firm Urges GRAIL, Inc. (NASDAQ: GRAL) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
Why Grail Could Be the Sleeper Stock Everyone's About to Notice ↗
Grail is on a quest to win in a $50 billion market. 
Via The Motley Fool
News headline image
SHAREHOLDER CLASS ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Grail (GRAL) Investors of Securities Class Action Deadline on August 4, 2026
From Faruqi & Faruqi, LLP
Via Business Wire
News headline image
Investor Notice: Robbins LLP Informs Investors of the Grail, Inc. Class Action Lawsuit
From Robbins LLP
Via Business Wire
News headline image
Here's Why Grail Stock Soared Higher in May (And Where the Company is Heading Now) ↗
Investors remain hopeful that the Galleri test can gain FDA approval and medical insurance coverage. 
Via The Motley Fool
Topics Death
News headline image
Why Grail Stock Popped Today ↗
The Galleri test failed its primary endpoint in a landmark trial, but that doesn't mean it doesn't have a big future. 
Via The Motley Fool
Topics Death
News headline image
Is Grail Stock a Bad-News Buy After Its Recent Pullback? ↗
The cancer test maker could still have a bright future. 
Via The Motley Fool
News headline image
Why Grail Shares Crashed Today ↗
The market was disappointed by the more detailed data on a landmark trial for the company's multi-cancer early detection (MCED) test. 
Via The Motley Fool
Topics Death
News headline image
GRAIL’s Galleri Test Cuts Stage 4 Cancer Diagnoses in Study Despite Missed Endpoint ↗
GRAIL (NASDAQ:GRAL) said new data presented at the American Society of Clinical Oncology annual meeting showed its Galleri multi-cancer early detection blood test can identify more cancers through... 
Via MarketBeat
News headline image
Grail's Slump Enters Week 10. Is There Any End in Sight? ↗
Despite a disappointing trial result, there's still a case for buying the stock, with a near-term catalyst on the horizon. 
Via The Motley Fool
News headline image
This Beaten-Down Growth Stock Could Soar 30%, According to Wall Street ↗
Grail's Galleri trial was disappointing, but it isn't down for the count yet. 
Via The Motley Fool
News headline image
GRAIL Says Galleri Demand Is Rising as NHS Talks, FDA Review Move Ahead ↗
GRAIL (NASDAQ:GRAL) said demand for its Galleri multi-cancer early detection test has continued to grow despite recent headlines related to its NHS study, according to comments made by Aaron, who... 
Via MarketBeat
News headline image
Here's Why Grail Shares Popped Higher This Week ↗
The company recently reported better-than-expected results, and investors are hoping for more positive news at the end of the month. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.